-34.1%
MRNA vs GEHC
+2.6%
-36.7%
-89.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GEHC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -1.4% | +2.2% | +1.5% |
| 7D | -8.2% | -7.9% | -0.4% | -4.0% |
| 30D | +125.6% | -11.7% | +137.3% | +144.0% |
| 3M | +197.1% | +0.8% | +196.3% | +200.5% |
| 6M | +148.5% | -11.6% | +160.1% | +165.9% |
| YTD | +363.3% | -21.6% | +384.8% | +422.0% |
| 1Y | +462.0% | -15.3% | +477.3% | +512.2% |
| 3Y | +26.9% | -0.5% | +27.4% | +33.2% |
| All | -34.1% | +2.6% | -36.7% | -33.0% |
Cumulative growth
Daily Returns
Daily percentage return beside GEHC.
Daily Out/Under-Performance
Portfolio return minus GEHC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GEHC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GEHC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling